| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Pharmacology, National University of Singapore, Singapore, Singapore; Deartment of Pharmacology, School of Pharmacy, Fudan University, Shanghai, China
2 Emergency Department, National University Hospital, Singapore, Singapore
3 Department of Pharmacology, National University of Singapore, Singapore, Singapore
4 Department of Biochemistry, National University of Singapore, Singapore, Singapore
* To whom correspondence should be addressed. E-mail: phczhuyz{at}nus.edu.sg.
In our current study, we aimed to determine whether nitroparacetamol (NO donor) and paracetamol exhibit cardioprotective effects. Myocardial infarction (MI) was induced in Wistar rats and drug treatment was started 1 week before surgery. Mortality rate at 2 days after MI induction was compared. Male Wistar rats weighing between 220-250 g were used. Treatment groups included vehicle (saline), paracetamol and nitroparacetamol (NO-paracetamol). These drugs were given via the intraperitoneal route at doses of 5mg/kg/day, 5mg/kg/day and 15 mg/kg/day, respectively. Mortality rate for vehicle (n=80), paracetamol (n=79) and NO-paracetamol (n=76), groups were 37.5%, 21.5% and 26.3%, respectively. A corresponding reduction in infarction size in the groups with better survival rate was noted. Thus, infarction size for the vehicle group was 44.8% (±6.1%) of the left ventricle (LV). For the paracetamol and NO-paracetamol groups, infarction size was 31.3% (±5.6%) and 30.7% (± 8.1%) of the LV, respectively. NO-paracetamol and paracetamol administration in this way did not have any discernible effects on blood pressure or post-myocardial infarction temperature in these animals. Both paracetamol and NO-paracetamol treated groups showed increased activities of Catalase (CAT) and superoxide dismutase (SOD) compared to the vehicle group. They could attenuate eNOS, iNOS, nNOS, COX-1 and COX-2 genes expression after MI. The observation that both nitroparacetamol and paracetamol produce a lower mortality rate than vehicle indicates the potential clinical significance of the cardioprotective effects of these drugs.
This article has been cited by other articles:
|
|
 |
|
  N. M. Hadzimichalis, S. S. Baliga, R. Golfetti, K. M. Jaques, B. L. Firestein, and G. F. Merrill Acetaminophen-mediated cardioprotection via inhibition of the mitochondrial permeability transition pore-induced apoptotic pathway Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3348 - H3355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Chuah, P. K. Moore, and Y. Z. Zhu S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2693 - H2701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Merrill, J. H. Merrill, R. Golfetti, K. M. Jaques, N. S. Hadzimichalis, S. S. Baliga, and T. H. Rork Antiarrhythmic Properties of Acetaminophen in the Dog Experimental Biology and Medicine, October 1, 2007; 232(9): 1245 - 1252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Fu, Z. Wang, W. L. Chen, P. K. Moore, and Y. Z. Zhu Cardioprotective effects of nitric oxide-aspirin in myocardial ischemia-reperfused rats Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1545 - H1552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Z. Zhu, Z. J. Wang, P. Ho, Y. Y. Loke, Y. C. Zhu, S. H. Huang, C. S. Tan, M. Whiteman, J. Lu, and P. K. Moore Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats J Appl Physiol, January 1, 2007; 102(1): 261 - 268. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
